Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases

Chimeric antigen receptor T (CAR-T) cells are T cells engineered to express specific synthetic antigen receptors that can recognize antigens expressed by tumor cells, which after the binding of these antigens to the receptors are eliminated, and have been adopted to treat several kinds of malignanci...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuehong, Sun, Jianhong, Liu, Huan, Yin, Geng, Xie, Qibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012264/
https://www.ncbi.nlm.nih.gov/pubmed/32083141
http://dx.doi.org/10.1155/2019/5727516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012264/
https://www.ncbi.nlm.nih.gov/pubmed/32083141
http://dx.doi.org/10.1155/2019/5727516

Ejemplares similares